IDXX - Comprehensive Filing Intelligence

FY 2025•10-K•Filed Feb 20, 2026

6.0/10

Filing Health:GOOD

Solid fundamentals with minor concerns to monitor

Executive Summary

The company has purchase obligations of $207.3 million due in 2026 and $136.7 million beyond 2026.. Companion Animal Group revenue increased by 10.61% See detailed pass outputs for comprehensive analysis.

Top Concerns

!Gross profit margin improved by 80 basis points, benefiting from recurring revenue, operational productivity, and pricing, despite inflationary cost pressures.
!The company faces headwinds from macroeconomic factors and supply chain challenges, but has implemented strategies to mitigate these impacts.
!The company has purchase obligations of $207.3 million due in 2026 and $136.7 million beyond 2026.
!Management believes pending legal actions will not have a material effect, but acknowledges outcomes are uncertain.
!Intensifying competition and rapid technological advancement, especially AI, could erode market share and profitability. (high)

Top Positives

+Revenue growth was strong at 10.4%, driven primarily by the Companion Animal Group (CAG) segment, with recurring revenue being a key contributor.
+Operating expenses increased, primarily in sales & marketing and R&D, while G&A decreased due to a one-time litigation settlement.
+International revenue showed strong growth, particularly in CAG, indicating global demand for the company's products and services.

Analysis Dimensions

Our 5-pass AI analysis examines this filing across multiple dimensions. Each dimension score is derived from direct analysis of SEC filing text.

Narrative Intelligence

5.0/10

Management tone is confidently optimistic with focus on benefits from recurring revenue growth in idexx vetlab consumable and reference laboratory testing volumes.

Full analysis includes: tone changes vs prior quarter, margin driver breakdown, forward guidance analysis, strategic priorities.

Accounting Quality

8.0/10

Earnings quality shows conservative accounting practices.

Full analysis includes: reserve and allowance changes, non-recurring item analysis, stock-based compensation impact, disclosure concerns.

Hidden Liabilities

Off-balance sheet risk is low with $207.3 million in identified exposure.

Full analysis includes: cloud and purchase commitments, VIE/SPE exposure, covenant compliance status, refinancing risk assessment.

Risk Landscape

6.0/10

Overall risk profile shows intensifying competition and rapid technological advancement, especially ai, could erode market share and profitability. as primary concern.

Full analysis includes: 8 risk categories with severity, new vs escalated risks, management response assessment, risk trend analysis.

Segment Performance

8.0/10

Segment health analysis.

Full analysis includes: segment-by-segment revenue breakdown, geographic concentration risk, customer concentration analysis, segment margin trends.